OncoNano Medicine
Ashley Campbell is an Associate Research Scientist at OncoNano Medicine, Inc. since February 2018, where responsibilities include collaborating on cancer immunotherapy research, executing polymer synthesis, and using analytical instrumentation for project support. Prior experience includes serving as a Lab Assistant II at AIT Laboratories from May 2015 to July 2017, focusing on clinical data entry and sample preparation in compliance with HIPAA regulations. Ashley holds a Bachelor of Science in Chemistry from the University of North Texas, earned in 2017.
OncoNano Medicine
OncoNano Medicine is developing a new class of pH-activated compounds that digitalize and exploit the variability of pH in disease. pH variability is a proven, simple, and effective identifier of diseased tissue providing a foundation for the development of a broad range of highly targeted therapeutics and imaging agents.